Investing

Schrodinger : SDGR

SDGR

Stock Data

$0.00

$0.00 (0.00%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Schrodinger Inc is a pioneer in developing a computational platform designed to accelerate the discovery of novel molecules for both drug development and materials applications. With a focus on licensing its groundbreaking software, the company supports the life sciences and materials science industries in transforming molecular discovery. Additionally, Schrodinger is actively involved in drug discovery, working on a portfolio of preclinical and clinical programs on its own and through partnerships. Founded in 1990 and headquartered in New York, it serves a global clientele including biopharmaceutical companies, academic institutions, and government labs.

All Schrodinger Articles

4 Articles

Joel South | Jul 1, 2026 at 12:16 PM EDT

AMD Is Up 150% This Year But Here Are 5 Overlooked Stocks Betting on What Comes Next

The Pentagon just earmarked over $74 billion for drone dominance and counter drone technologies in the FY2027 budget request, and…

Rich Duprey | Jun 30, 2026 at 9:38 AM EDT

AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity

Artificial intelligence is reshaping nearly every industry, but some of its biggest opportunities are emerging far from Silicon Valley. Biotechnology…

Trey Thoelcke | May 18, 2026 at 7:35 AM EDT

7 Healthcare AI Stocks Under $50 With Huge Upside Potential

Healthcare AI stocks have been hammered in 2026, with several names down 30% to 65% year to date even as…

Eric Bleeker | Jun 1, 2024 at 1:08 PM EDT

1 Growth Stock That Could Dominate AI’s Next Breakthrough

This discussion explores secondary opportunities to benefit from the AI boom beyond the most talked about stocks like NVIDIA (NASDAQ:…